Drug recall · August 21, 2013
buPROPion Hydrochloride Extended Release Tablets recall
Why: Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01
- Lots / codes
The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.
- Quantity
- 389 cartons
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Nationwide
- Initiated
- February 4, 2013 · Voluntary: Firm initiated
- Classified
- August 15, 2013
- Reported
- August 21, 2013
- Ended
- August 28, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.